SNU Bio Angel

SNU Bio Angel is a Seoul-based venture capital firm specializing in strategic investments within the biotechnology and pharmaceutical sectors. The firm targets companies developing chemical and biological drugs, pharmaceutical research, and manufacturing. Its investment scope includes therapeutic technologies like immunotherapy, monoclonal antibodies, bispecific antibodies, and other biological preparations, advancing medical science.

Established as an investment vehicle, SNU Bio Angel emerged from the insight that specialized capital is vital for translating scientific breakthroughs into commercial solutions. The firm supports early-stage ventures within Korea's dynamic life sciences ecosystem, fostering innovation where significant R&D investments are critical.

SNU Bio Angel primarily invests in innovative startups and emerging companies across the biotechnology and pharmaceutical value chain. The firm aims for its strategic funding to facilitate commercialization of groundbreaking scientific discoveries into effective medical solutions. Its long-term vision involves cultivating a robust portfolio contributing significantly to human health and therapeutic progress.